Literature DB >> 4126124

Clofibrate, nephrotic syndrome, and histological changes in muscle.

M Denizot, J Fabre, D Pometta, E Wildi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4126124     DOI: 10.1016/s0140-6736(73)91351-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Clofibrate-induced myopathy in the rat.

Authors:  H Teräväinen; A Larsen; M Hillbom
Journal:  Acta Neuropathol       Date:  1977-08-16       Impact factor: 17.088

2.  Mitochondrial myopathy--a result of clofibrate/etofibrate treatment? Case report.

Authors:  A Bardosi; P Scheidt; H H Goebel
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

3.  Clofibrate-induced myotonia in the rat.

Authors:  A Eberstein; J Goodgold; R Johnston
Journal:  Experientia       Date:  1978-12-15

Review 4.  Renal failure, drug pharmacokinetics and drug action.

Authors:  J Fabre; L Balant
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

Review 5.  Adverse effects of drugs on muscle.

Authors:  F L Mastaglia
Journal:  Drugs       Date:  1982-10       Impact factor: 9.546

6.  [Bezafibrate-induced myolysis and myoglobinuria in patients with impaired renal function].

Authors:  K W Rumpf; M Barth; M Blech; H Kaiser; I Koop; R Arnold; F Scheler
Journal:  Klin Wochenschr       Date:  1984-04-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.